en

PRODUCT DETAIL

Betmiga 25 mg tablety s predĺženým uvoľňovaním

Code 9829A
MA number EU/1/12/809/016
Product Form: tbl plg 100x25 mg (blis.Al/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 73 - SPASMOLYTICA
ATC:
G GENITO URINARY SYSTEM AND SEX HORMONES
G04 UROLOGICALS
G04B UROLOGICALS (OTHER UROLOGICALS, INCL. ANTISPASMODICS-delete WHO)
G04BD Drugs for urinary frequency and incontinence (Urinary antispasmodics-delete-WHO)
G04BD12 Mirabegron
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 20.12.2012
SmPC + PL: European Medicines Agency's database
Dokument: DHPC Betmiga_Astellas 7 9 2015.pdf  
Safety feature Yes
Data update: 15.06.2018
eu-flag.png sk-flag.png